Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study

The pathological accumulation of parenchymal and vascular amyloid-beta (Aβ) are the main hallmarks of Alzheimer’s disease (AD) and Cerebral Amyloid Angiopathy (CAA), respectively. Emerging evidence raises an important contribution of vascular dysfunction in AD pathology that could partially explain...

Full description

Bibliographic Details
Main Authors: Paula Marazuela, Berta Paez-Montserrat, Anna Bonaterra-Pastra, Montse Solé, Mar Hernández-Guillamon
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/9/4972
_version_ 1797504509733240832
author Paula Marazuela
Berta Paez-Montserrat
Anna Bonaterra-Pastra
Montse Solé
Mar Hernández-Guillamon
author_facet Paula Marazuela
Berta Paez-Montserrat
Anna Bonaterra-Pastra
Montse Solé
Mar Hernández-Guillamon
author_sort Paula Marazuela
collection DOAJ
description The pathological accumulation of parenchymal and vascular amyloid-beta (Aβ) are the main hallmarks of Alzheimer’s disease (AD) and Cerebral Amyloid Angiopathy (CAA), respectively. Emerging evidence raises an important contribution of vascular dysfunction in AD pathology that could partially explain the failure of anti-Aβ therapies in this field. Transgenic mice models of cerebral β-amyloidosis are essential to a better understanding of the mechanisms underlying amyloid accumulation in the cerebrovasculature and its interactions with neuritic plaque deposition. Here, our main objective was to evaluate the progression of both parenchymal and vascular deposition in APP23 and 5xFAD transgenic mice in relation to age and sex. We first showed a significant age-dependent accumulation of extracellular Aβ deposits in both transgenic models, with a greater increase in APP23 females. We confirmed that CAA pathology was more prominent in the APP23 mice, demonstrating a higher progression of Aβ-positive vessels with age, but not linked to sex, and detecting a pronounced burden of cerebral microbleeds (cMBs) by magnetic resonance imaging (MRI). In contrast, 5xFAD mice did not present CAA, as shown by the negligible Aβ presence in cerebral vessels and the occurrence of occasional cMBs comparable to WT mice. In conclusion, the APP23 mouse model is an interesting tool to study the overlap between vascular and parenchymal Aβ deposition and to evaluate future disease-modifying therapy before its translation to the clinic.
first_indexed 2024-03-10T04:05:36Z
format Article
id doaj.art-a7257fcbf62841b4a32b49bac6ba169d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:05:36Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a7257fcbf62841b4a32b49bac6ba169d2023-11-23T08:25:00ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01239497210.3390/ijms23094972Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological StudyPaula Marazuela0Berta Paez-Montserrat1Anna Bonaterra-Pastra2Montse Solé3Mar Hernández-Guillamon4Neurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainThe pathological accumulation of parenchymal and vascular amyloid-beta (Aβ) are the main hallmarks of Alzheimer’s disease (AD) and Cerebral Amyloid Angiopathy (CAA), respectively. Emerging evidence raises an important contribution of vascular dysfunction in AD pathology that could partially explain the failure of anti-Aβ therapies in this field. Transgenic mice models of cerebral β-amyloidosis are essential to a better understanding of the mechanisms underlying amyloid accumulation in the cerebrovasculature and its interactions with neuritic plaque deposition. Here, our main objective was to evaluate the progression of both parenchymal and vascular deposition in APP23 and 5xFAD transgenic mice in relation to age and sex. We first showed a significant age-dependent accumulation of extracellular Aβ deposits in both transgenic models, with a greater increase in APP23 females. We confirmed that CAA pathology was more prominent in the APP23 mice, demonstrating a higher progression of Aβ-positive vessels with age, but not linked to sex, and detecting a pronounced burden of cerebral microbleeds (cMBs) by magnetic resonance imaging (MRI). In contrast, 5xFAD mice did not present CAA, as shown by the negligible Aβ presence in cerebral vessels and the occurrence of occasional cMBs comparable to WT mice. In conclusion, the APP23 mouse model is an interesting tool to study the overlap between vascular and parenchymal Aβ deposition and to evaluate future disease-modifying therapy before its translation to the clinic.https://www.mdpi.com/1422-0067/23/9/4972APP235xFADcerebral β-amyloidosispreclinical MRIcerebral microbleeds
spellingShingle Paula Marazuela
Berta Paez-Montserrat
Anna Bonaterra-Pastra
Montse Solé
Mar Hernández-Guillamon
Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
International Journal of Molecular Sciences
APP23
5xFAD
cerebral β-amyloidosis
preclinical MRI
cerebral microbleeds
title Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
title_full Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
title_fullStr Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
title_full_unstemmed Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
title_short Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
title_sort impact of cerebral amyloid angiopathy in two transgenic mouse models of cerebral β amyloidosis a neuropathological study
topic APP23
5xFAD
cerebral β-amyloidosis
preclinical MRI
cerebral microbleeds
url https://www.mdpi.com/1422-0067/23/9/4972
work_keys_str_mv AT paulamarazuela impactofcerebralamyloidangiopathyintwotransgenicmousemodelsofcerebralbamyloidosisaneuropathologicalstudy
AT bertapaezmontserrat impactofcerebralamyloidangiopathyintwotransgenicmousemodelsofcerebralbamyloidosisaneuropathologicalstudy
AT annabonaterrapastra impactofcerebralamyloidangiopathyintwotransgenicmousemodelsofcerebralbamyloidosisaneuropathologicalstudy
AT montsesole impactofcerebralamyloidangiopathyintwotransgenicmousemodelsofcerebralbamyloidosisaneuropathologicalstudy
AT marhernandezguillamon impactofcerebralamyloidangiopathyintwotransgenicmousemodelsofcerebralbamyloidosisaneuropathologicalstudy